Marsi Bionics
- Company typePrivate
- Founded2013
- HeadquartersVaciamadrid, Spain
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Marsi Bionics firmographics
Firmographics- Name
- Marsi Bionics
- Legal name
- MARSI BIONICS S.L
- Website
- https://marsibionics.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Marsi Bionics industry classification
Industry- Product category
- Medical Exoskeletons & Rehabilitation Robotics
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Pediatric Rehabilitation & Mobility DME (Adaptive Seating, Pediatric Mobility) (HLAHAMAI)
- akta.pro secondary industries
- Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG), Healthcare & Assistive Robotics (HDAAAIAC), Orthotics & Bracing (Spinal/Lower/Upper Extremity Orthoses) (HLAHAEAI), Prosthetics/Orthotics Rehab & Amputee Rehabilitation (HSADAIAN)
Keywords
Where Marsi Bionics is headquartered
LocationHeadquarters
- HQ city
- Vaciamadrid
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
Marsi Bionics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Medical Device Sales: Marsi Bionics generates revenue through the sale of robotic medical exoskeleton devices including Atlas 2030 pediatric exoskeleton, EXPLORER MB personal exoskeleton, and MB-Active Knee robotic orthosis to hospitals, rehabilitation centers, and healthcare providers.
- Clinical Therapy Services: Marsi Care platform provides robot-assisted research and therapy services for neurological diseases. The public-private collaboration between CSIC and Marsi Bionics offers patients access to cutting-edge therapies and participates in clinical research programs.
- International Distribution: Revenue generated through authorized distributors including Medimex (France), Skyfi (Poland), and Rehagirona (Spain) who resell and distribute Marsi Bionics products in their respective territories.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom quote-based pricing for medical institutions |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels6 records
Marsi Bionics product offering
Product offeringCore offering
Marsi Bionics develops and manufactures self-adaptive gait exoskeletons and robotic orthoses for clinical rehabilitation and mobility assistance, built on its proprietary ARES (Actively Responsive Exoskeleton System) technology with variable-stiffness active joints. The company sells the Atlas 2030 pediatric exoskeleton, the EXPLORER MB personal-use pediatric exoskeleton, the MB-Active Knee robotic knee orthosis, and operates the Marsi Care clinical therapy platform in collaboration with CSIC. Devices are targeted at hospitals, rehabilitation centers, and pediatric neurorehabilitation institutions treating patients with cerebral palsy, spinal muscular atrophy, stroke, and post-surgical knee conditions.
Product overview
Marsi Bionics develops innovative gait exoskeleton technology based on proprietary ARES technology with active joints and variable stiffness that mimics natural muscle function. The product portfolio consists of three core devices: Atlas 2030 (pediatric exoskeleton for clinical rehabilitation of children with neuromuscular conditions), EXPLORER MB (first pediatric exoskeleton for personal/home use for children with neurodevelopmental disorders aged 2-17), and MAK Active Knee (robotic knee orthosis for adult rehabilitation after surgery or stroke). The company also operates Marsi Care, a clinical research and therapy platform for robot-assisted neurorehabilitation. The products are designed for rehabilitation of a wide range of neurological conditions affecting over 40 million patients worldwide.
Differentiator
Problem solved
Functional benefit
Brands
- Atlas 2030: Pediatric exoskeleton designed to assist children with neuromuscular conditions in walking and rehabilitation therapy.
- EXPLORER MB
- MB-Active Knee
- Marsi Care
Products and services
- Atlas 2030 Pediatric Exoskeleton
Quantifiable outcome
- Improvement in gross motor function in children with cerebral palsy after rehabilitation with Atlas 2030
- +4 more outcomes
Companies that use Marsi Bionics
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles1 record
Marsi Bionics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Marsi Bionics partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship and minor.
- CSIC (Spanish National Research Council)flagshipPublic-private collaboration between CSIC and Marsi Bionics established the Marsi Care platform for robot-assisted research and therapy. CSIC provides research expertise and institutional credibility through the Centre for Automation and Robotics (CSIC-UPM).
- RehakindminorMarsi Bionics is listed as a member of Rehakind organization, indicating participation in a pediatric rehabilitation industry network.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Marsi Bionics competitors and assessment
Company assessmentDirect peers
- Hocoma: Hocoma (Switzerland) is a leading provider of robotic and sensor-based medical devices for rehabilitation, including the Lokomat gait trainer and Armeo products. It is a direct competitor in hospital-based robotic gait rehabilitation, often sold into the same pediatric and adult rehabilitation centers that Marsi Bionics targets.
- Wandercraft: Wandercraft is a French robotics company developing self-balancing Atalante personal and clinical exoskeletons for patients with mobility impairments. As a European peer with similar ARES-comparable technology and gait rehabilitation focus, it is a close direct competitor in the same geographies as Marsi Bionics.
- Cyberdyne: Cyberdyne (Japan) produces the HAL (Hybrid Assistive Limb) robotic exoskeleton for medical and welfare applications. It is a direct competitor in the medical exoskeleton space with established hospital deployments, particularly in Asia, and shares Marsi Bionics' gait rehabilitation focus.
- Ekso Bionics: Ekso Bionics is a publicly listed developer of exoskeletons for medical and industrial use. It is the most direct competitor to Marsi Bionics in the rehabilitation exoskeleton category, with overlapping hospital customers and similar robotic gait-assist devices (e.g., EksoNR for stroke and spinal cord injury).
- Parker Hannifin (Indego): Parker Hannifin's Indego is a powered exoskeleton for individuals with spinal cord injury, marketed through Vanderbilt license. It competes directly with Marsi Bionics in the clinical gait rehabilitation exoskeleton segment, with FDA-cleared and CE-marked devices distributed through hospital networks.
- ReWalk Robotics: ReWalk Robotics develops wearable robotic exoskeletons for spinal cord injury and stroke rehabilitation, with FDA-cleared personal and rehabilitation systems. It competes head-on with Marsi Bionics in the gait rehabilitation exoskeleton category for clinical use.
- Rex Bionics: Rex Bionics (New Zealand) produces the REX robotic exoskeleton for people with mobility impairments. While it focuses more on self-supporting standing and walking rather than gait training, it competes with Marsi Bionics in the powered clinical exoskeleton category for rehabilitation and mobility assistance.
Emerging players
- Bionik Laboratories: Bionik Laboratories develops robotic rehabilitation devices for stroke and other neurological conditions, including the InMotion ARM and InMotion ANKLE systems. It is a smaller emerging player in rehabilitation robotics with partial overlap to Marsi Bionics' clinical rehabilitation focus.
- Tyromotion: Tyromotion (Austria) develops robotic-assisted therapy devices for upper extremity and gait rehabilitation, including the OMEGO and LEXO systems. It is an emerging European peer with partial overlap to Marsi Bionics' pediatric and adult rehabilitation focus.
Others
- CSIC (Spanish National Research Council) - Centre for Automation and Robotics: CSIC's Centre for Automation and Robotics is the public research institution from which Marsi Bionics was spun off in 2013 and continues to collaborate through the Marsi Care platform. It is an enabling research partner rather than a competitor, providing foundational IP, clinical collaboration, and institutional credibility.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Marsi Bionics social profiles
Digital presenceMarsi Bionics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Marsi Bionics leadership team
Management profileNumber of profiles
Profiles8 records
Marsi Bionics funding detail
Funding detailFunding overview
Funding rounds6 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Marsi Bionics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Marsi Bionics
What does Marsi Bionics do?
Marsi Bionics develops and manufactures self-adaptive gait exoskeletons and robotic orthoses for clinical rehabilitation and mobility assistance, built on its proprietary ARES (Actively Responsive Exoskeleton System) technology with variable-stiffness active joints. The company sells the Atlas 2030 pediatric exoskeleton, the EXPLORER MB personal-use pediatric exoskeleton, the MB-Active Knee robotic knee orthosis, and operates the Marsi Care clinical therapy platform in collaboration with CSIC. Devices are targeted at hospitals, rehabilitation centers, and pediatric neurorehabilitation institutions treating patients with cerebral palsy, spinal muscular atrophy, stroke, and post-surgical knee conditions.
Is Marsi Bionics a public or private company?
Marsi Bionics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Marsi Bionics founded?
Marsi Bionics was founded in 2013. It employs 11 to 50 people.
Where is Marsi Bionics based?
Marsi Bionics is headquartered in Vaciamadrid, Spain, in the Europe region.
How does Marsi Bionics make money?
Three revenue lines are on record. Medical Device Sales are the primary driver. The others are clinical Therapy Services and international Distribution.
Who are Marsi Bionics's main competitors?
Direct peers on record are Hocoma, Wandercraft, Cyberdyne, Ekso Bionics, Parker Hannifin (Indego), ReWalk Robotics and Rex Bionics. Emerging players are Bionik Laboratories and Tyromotion. CSIC (Spanish National Research Council) - Centre for Automation and Robotics is listed as an others.
Does Marsi Bionics have an API?
No public API is recorded for Marsi Bionics.
What industry is Marsi Bionics in?
Marsi Bionics's product category is Medical Exoskeletons & Rehabilitation Robotics. Its primary akta.pro industry code is HLAHAMAI, Pediatric Rehabilitation & Mobility DME (Adaptive Seating, Pediatric Mobility), with a secondary code of HLAHAMAG, Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices). Its NAICS code is 334510 and its SIC code is 3842.